Close

EBS Financial Facts

Total revenues: 142.91M
Cost of product sales: 39.56M
See Full Income Statement

Total current liabilities: 110.31M
Total liabilities: 384.4M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date 4/25/24 EPS Growth Rate +99.1%
Average EPS % Beat Rate -421.0% Revenue Growth Rate +12.3%
Average % Move 1-Wk after EPS -23.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/18/21 Q420 $3.67$3.19 +$0.48$583M$563.94M = Details
11/5/20 Q320 $2.19$2.12 +$0.07$385.2M$437.93M Details
7/30/20 Q220 $1.98$0.68 +$1.30$394.7M$294.73M Details
4/30/20 Q120 $0.01$0.01 $0.00$192.5M$199.47M Details
2/20/20 Q419 $1.57$1.73 -$0.16$360.4M$357.41M Details
7/29/21 Q221 $0.33$1.54 -$1.21$397.5M$398.93M = Details
2/21/19 Q418 $0.75$0.62 +$0.13$270.7M$270.03M = Details
11/1/18 Q318 $0.55$0.58 -$0.03$173.7M$184.1M = Details